一品红药业集团股份有限公司 按照《上市公司监管指引第 8 号——上市公司资金往来、对外担保的监管要求》(证监会公告[2022]26 号文）及其他相关规定，公 司 2025 年半年度非经营性资金占用及其他关联资金往来情况如下表所示： 上市公司 2025 年半年度非经营性资金占用及其他关联资金往来情况汇总表 | | | | | | | | 单位：元 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 占用方与上 | 上市公司核 | | 2025 年半年度占 | | 2025 年半年度 | | | | | 非经营性资 | 资金占用方名称 | | 市公司的关 | 2025 年半年度期 算的会计科 | | 年度占用 用累计发生金额 | | 2025 年半年度期 偿还累计发生 | 占用形 | 占 | | 用性质 | | | | | | | | | | | | 金占用 | | | | 初占用资金余额 | | 资金的利 | | 末占用资金余额 | 成原因 | | | | | 联关系 | 目 | | （不含利息） | ...

Group 1 - The document reports on the financial status of Wuxi Xinan Technology Co., Ltd. as of June 30, 2025, indicating that there are no non-operating fund occupations or related party transactions recorded [1][1][1] - The total amount of funds occupied and related party transactions is reported as zero, suggesting a clean financial slate with no outstanding obligations or liabilities in these areas [1][1][1] - The document includes details about the legal representatives and accounting personnel, confirming the governance structure of the company [1][1][1] Group 2 - The report emphasizes that there are no financial interactions with controlling shareholders, actual controllers, or their affiliated enterprises, indicating a lack of financial entanglements [1][1][1] - The absence of any recorded amounts for other related parties further reinforces the company's straightforward financial dealings [1][1][1] - The document serves as a formal financial statement, ensuring transparency and compliance with regulatory requirements [1][1][1]

经贸有限公司 及其附属企业 其他关联方及其附 属企业 总计 - - - 0.20 0.10 0.30 - | 编制单位：哈尔滨敷尔佳科技股份有限公 | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 司 | | | | | | | | | | 单位：万元 | | | | | 占用方与上 | 上市公司核 | 2025 | 2025 年期 | 年 | 1-6 月占 | 2025 | 1-6 年 | 2025 月 | 1- 年 | | 6 2025 6 年 | 月 | | | | | | | | | | | | 资金占用方 | | | | | | | | | | | | | 占用形 | | | | | | | | | | | | | 非经营性资金占用 | | | 市公司的关 | 算的会计科 | 初占用资 | | 用累计发生金额 | | 占用资金的利 | | 月偿还 | | 累计 30 日期末占 | | | | | 占用性质 | | | | | | | | 名称 | | ...

Summary of Key Points Core Viewpoint - The report provides a summary of non-operating fund occupation and other related fund transactions for Feitian Technology Co., Ltd. for the first half of 2025, highlighting the financial interactions with related parties and the amounts involved. Group 1: Non-Operating Fund Occupation - The report details the non-operating fund occupation by related parties, indicating that there are no amounts listed for the beginning and end of the period, suggesting no significant non-operating fund occupation [1]. - The report includes a breakdown of the amounts involved, with specific references to the nature of the occupation and the reasons for the fund occupation, although no specific figures are provided in this section [1]. Group 2: Other Related Fund Transactions - The report outlines the transactions with related parties, including accounts receivable and other receivables, with specific amounts listed for various subsidiaries [2]. - Total accounts receivable from subsidiaries amount to 1,636.80 million, indicating significant operational interactions with these entities [2]. - The report also mentions the total amount of transactions with other related parties, which is 2,004.66 million, reflecting the scale of financial dealings within the group [2].

Summary of Key Points Core Viewpoint - The documents provide detailed financial data regarding the accounts receivable and other financial interactions of Shandong Linuo Pharmaceutical Packaging Co., Ltd. with its related parties, highlighting significant amounts in both operating and non-operating transactions. Group 1: Accounts Receivable - The total accounts receivable from various related parties includes significant amounts such as 9.80 million from Shandong Hongjitang Pharmaceutical Group and 2.56 million from Hongjitang Bianque Chinese Medicine Pharmacy [1][2] - Other notable accounts receivable include 18.21 million from Linuo International Trade Co., Ltd. and 13.60 million from another related entity [2][3] - The company has a total of 240.25 million in accounts receivable, with a breakdown showing substantial amounts owed by various subsidiaries and related parties [3] Group 2: Financial Transactions - The documents indicate that there are non-operating fund usages amounting to significant figures, although specific amounts are not detailed in the provided text [1] - The financial interactions also include prepayments and other receivables, with 169.18 million noted for prepayments to a related gas company [3] - The total financial transactions involving related parties reflect a complex web of inter-company dealings, emphasizing the importance of monitoring these relationships for financial health [3]

Group 1 - The company held its first special meeting of the sixth board of independent directors on August 8, 2025, with all four independent directors participating in the vote [1] - The meeting reviewed and approved the proposal regarding the non-operating fund occupation and other related fund transactions for the first half of 2025, confirming that all transactions with related parties were normal and did not harm the interests of the company or minority shareholders [1] - The voting results showed unanimous approval with 4 votes in favor, 0 against, and 0 abstentions [1]

| 陕西汉江药业集团股份有限公司 | | | | 子公司 | 应收股利 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 7,088.26 | - | - | | 7,088.26 | - | 分配股利 | 非经营性往来 | | | | 重庆华邦制药有限公司 | | | | 子公司 | 应收股利 | | 40,036.98 | 8,025.93 | - | | 48,062.91 | - | 分配股利 | 非经营性往来 | | | | | | | | 其他关联方及其附属 | 重庆松山医院 | | | | 其他关联方 | 应收账款 | 25,624.91 | | | | 12,194.67 | | 2,904.75 | | | 34,914.83 销售及租赁等业务 | 经营性往来 | | | | | 企业 | 重庆松山医院 | | | 其他关联方 | 其他应收款 | | 45,150.61 | 14,126.00 | | | 751.67 | 18,226.00 | 41,802.28 | | 借款 非经营性往来 ...

单位：万元 占用方与上 非经营性资 上市公司核算 2025 年期初占 2025 半年度占用累计 2025 半年度占用资 2025 半年度偿还 2025 半年期末占 占用形 占用性 资金占用方名称 市公司的关 金占用 的会计科目 用资金余额 发生金额（不含利息） 金的利息（如 有） 累计发生金额 用资金余额 成原因 质 联关系 现大股东 及 非经营 其附属企 业 性占用 小 计 - - - - 前大股东 及 非经营 其附属企 业 性占用 小 计 - - - - 总 计 - - - 往来方与上 其它关联资 上市公司核算 2025 年期初往 2025 半年度往来累计 2025 半年度往来资 2025 半年度偿还 2025 年半年期末 往来形 往来性 资金往来方名称 市公司的关 金往来 的会计科目 来资金余额 发生金额（不含利息） 金的利息（如 有） 累计发生金额 往来资金余额 成原因 质 联关系 大股东及其 江西阳光乳业集团有 限 房 产 租 经营性 附属企业 公司 控股股东 应付账款 0 46.20 0 46.20 赁 往来 上市公司的 江西长山现代有机牧 场 非经营 子公司及其 有限公司 子公司 其他应收款 1 ...

| 编制单位：江苏捷捷微电子股份有限公 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | | | | | | | | | 司 | | | | | | | | | | | 单位：人民币万元 | | | | | | 占用方与 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2025 年 6 月末占 | | | | | | | | | | | | | | | 上市公司 上市公司核算 | | | | 非经营性资金占用 | 资金占用方名称 | ...

北京恒华伟业科技股份有限公司 | 单位：万元 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 占用方与上 | 上市公司 | 2025 年期 | 2025 | 年半年度占 | 2025 年半年 | 2025 年 | | 半年 | 2025 年半年 | 占用 | | | | | | | | 非经营性 | | 资金占用 | | | | | | | | | | 市公司的关 | 核算的会 | 初占用资 | | 用累计发生金额 | 度占用资金的 | | | 度偿还累计 | | 度期末占用 | 形成 | 占用性质 | | | | | | 资金占用 | 方名称 | | | | | | | | | | | 联关系 | 计科目 | 金余额 | （不含利息） | | 利息（如有） | 发生金 | | 额 | 资金余额 | | 原因 | | | | | | | 控股股东、 | | | | | | | | | | 实 | | | | | | | | 非经 | | 营性占用 | | | | | | | | | | 际控制人及其 ...